BRPI0812170A2 - Moduladores de gama secretase - Google Patents

Moduladores de gama secretase

Info

Publication number: BRPI0812170A2
Authority: BR; Brazil
Prior art keywords: secretase; range modulators; modulators; range; secretase range
Prior art date: 2007-06-01

Application number

BRPI0812170-2A2A

Other languages

English (en)

Inventor

Zhaoning Zhu

William J Greenlee

Xianhai Huang

Brian A Mckittrick

John W Clader

Mark D Mcbriar

Anandan Palani

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-06-01

Filing date

2008-05-28

Publication date

2014-12-02

2008-05-28 Application filed by Schering Corp filed Critical Schering Corp

2014-12-02 Publication of BRPI0812170A2 publication Critical patent/BRPI0812170A2/pt

2016-02-10 Publication of BRPI0812170A8 publication Critical patent/BRPI0812170A8/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

BRPI0812170A 2007-06-01 2008-05-28 Moduladores de gama secretase BRPI0812170A8 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US94140507P	2007-06-01	2007-06-01
US98448407P	2007-11-01	2007-11-01
PCT/US2008/006734 WO2008153793A2 (en)	2007-06-01	2008-05-28	Gamma secretase modulators

Publications (2)

Publication Number	Publication Date
BRPI0812170A2 true BRPI0812170A2 (pt)	2014-12-02
BRPI0812170A8 BRPI0812170A8 (pt)	2016-02-10

Family

ID=40084164

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0812170A BRPI0812170A8 (pt)	2007-06-01	2008-05-28	Moduladores de gama secretase

Country Status (18)

Country	Link
US (1)	US8426403B2 (pt)
EP (1)	EP2152695A2 (pt)
JP (1)	JP5495331B2 (pt)
KR (1)	KR20100037053A (pt)
CN (1)	CN101809016A (pt)
AR (1)	AR066152A1 (pt)
AU (1)	AU2008263207B2 (pt)
BR (1)	BRPI0812170A8 (pt)
CA (1)	CA2689948A1 (pt)
CL (1)	CL2008001560A1 (pt)
CO (1)	CO6241123A2 (pt)
EC (1)	ECSP099776A (pt)
IL (1)	IL202315A0 (pt)
MX (1)	MX2009013131A (pt)
PE (1)	PE20090363A1 (pt)
RU (1)	RU2009148866A (pt)
TW (1)	TW200914459A (pt)
WO (1)	WO2008153793A2 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2008097538A1 (en) *	2007-02-08	2008-08-14	Merck & Co., Inc.	Therapeutic agents
WO2010054067A1 (en) *	2008-11-06	2010-05-14	Schering Corporation	Gamma secretase modulators
RU2011123862A (ru)	2008-11-13	2012-12-20	Шеринг Корпорейшн	Модуляторы гамма-секретазы
CA2742472A1 (en) *	2008-11-13	2010-05-20	Schering Corporation	Gamma secretase modulators
AR074702A1 (es) *	2008-12-22	2011-02-02	Schering Corp	Moduladores de gamma secretasa y composiciones farmaceuticas que los contienen
US20120232108A1 (en) *	2009-06-16	2012-09-13	Xianhai Huang	Gamma secretase modulators
EP2443119A1 (en) *	2009-06-16	2012-04-25	Schering Corporation	Gamma secretase modulators
EP2443121A2 (en) *	2009-06-16	2012-04-25	Schering Corporation	Gamma secretase modulators
JP2014001142A (ja) *	2010-10-05	2014-01-09	Astellas Pharma Inc	シクロアルカン化合物
ES2602794T3 (es)	2011-03-31	2017-02-22	Pfizer Inc	Piridinonas bicíclicas novedosas
UA110688C2 (uk)	2012-09-21	2016-01-25	Пфайзер Інк.	Біциклічні піридинони
US9598437B2 (en)	2013-12-04	2017-03-21	Merck Sharp & Dohme Corp.	Gamma secretase modulators
WO2016057931A1 (en)	2014-10-10	2016-04-14	The Research Foundation For The State University Of New York	Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration
BR112017015693A2 (pt)	2015-02-03	2018-03-20	Pfizer	ciclopropabenzofuranil piridopirazinadionas
US20230137562A1 (en)	2017-06-07	2023-05-04	Adrx, Inc.	Tau aggregation inhibitors
AU2018318319A1 (en)	2017-08-18	2020-02-20	Adrx, Inc.	Tau aggregation peptide inhibitors
JP7200005B2 (ja)	2018-02-28	2023-01-06	日本たばこ産業株式会社	飽和環縮合ジヒドロピリミジノン又はジヒドロトリアジノン化合物及びその医薬用途
WO2020113077A1 (en)	2018-11-29	2020-06-04	The Research Foundation For The State University Of New York	Compositions and methods for modular control of bioorthogonal ligation

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1065324A (en) *	1974-05-13	1979-10-30	E.R. Squibb And Sons	2-aminoalkyl-3,3a,4,5,6,7-hexahydro-3-phenyl-7-(phenylmethylene)-2h-indazoles and related cyclohepta (c) pyrazoles and cyclopentapyrazoles
CH594667A5 (en) *	1974-05-31	1978-01-13	Squibb & Sons Inc	Hexahydro-2H-pyrazolo(4,3-C) pyridine derivs
US3979381A (en) *	1975-08-11	1976-09-07	E. R. Squibb & Sons, Inc.	Thiopyrano[4,3-c] pyrazoles
US4003890A (en) *	1976-05-27	1977-01-18	E. R. Squibb & Sons, Inc.	Benzylidene pyrano[4,3-c]pyrazoles
US4065617A (en) *	1977-02-04	1977-12-27	E. R. Squibb & Sons, Inc.	2-(2,2,2,-Trifluoroethyl)-3,3a,4,5,6,7-hexahydro-2H-pyrazolo[4,3-c]pyridines
JP2002507610A (ja) *	1998-03-25	2002-03-12	ブリストル−マイヤーズスクイブカンパニー	イミダゾロン食欲抑制薬：ｉｉｉ．ヘテロアリール誘導体
CZ20023110A3 (cs) *	2000-03-20	2003-02-12	N-Gene Research Laboratories Inc.	Deriváty amidoximu propenkarboxylové kyseliny, způsob jejich přípravy a farmaceutické přípravky je obsahující
EP1603548A4 (en)	2003-02-05	2007-10-10	Myriad Genetics Inc	METHOD AND COMPOSITION FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
US7244739B2 (en)	2003-05-14	2007-07-17	Torreypines Therapeutics, Inc.	Compounds and uses thereof in modulating amyloid beta
AU2004311577A1 (en)	2003-07-11	2005-07-21	Myriad Genetics, Inc.	Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease
US20070293538A1 (en)	2004-04-13	2007-12-20	Myriad Genetics, Incorporated	Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
JP2007538024A (ja)	2004-05-19	2007-12-27	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	アミロイドベータペプチドのレベル変化に関連する疾患及び状態の治療方法及び新規エノールカルボキサミド化合物
MY149038A (en)	2004-05-26	2013-07-15	Eisai R&D Man Co Ltd	Cinnamide compound
EP1650183A1 (en)	2004-10-21	2006-04-26	Cellzome Ag	(Benzyloxy-biphenyl) acetic acids and derivatives thereof and their use in therapy
TWI370130B (en) *	2005-11-24	2012-08-11	Eisai R&D Man Co Ltd	Two cyclic cinnamide compound
EP1953154A4 (en) *	2005-11-24	2013-11-20	Eisai R&D Man Co Ltd	CINNAMIDE COMPOUNDS OF MORPHOLINE TYPE
KR101464651B1 (ko) *	2006-03-09	2014-11-24	에자이 알앤드디 매니지먼트 가부시키가이샤	다환식 신나미드 유도체
AU2008248129B8 (en)	2007-05-07	2013-05-30	Merck Sharp & Dohme Corp.	Gamma secretase modulators
US8580956B2 (en)	2007-06-01	2013-11-12	Merck Sharp & Dohme Corp.	Gamma secretase modulators
RU2011123862A (ru)	2008-11-13	2012-12-20	Шеринг Корпорейшн	Модуляторы гамма-секретазы

2008
- 2008-05-28 RU RU2009148866/04A patent/RU2009148866A/ru not_active Application Discontinuation
- 2008-05-28 JP JP2010510316A patent/JP5495331B2/ja not_active Expired - Fee Related
- 2008-05-28 MX MX2009013131A patent/MX2009013131A/es not_active Application Discontinuation
- 2008-05-28 BR BRPI0812170A patent/BRPI0812170A8/pt not_active IP Right Cessation
- 2008-05-28 EP EP08767902A patent/EP2152695A2/en not_active Withdrawn
- 2008-05-28 CN CN200880100987A patent/CN101809016A/zh active Pending
- 2008-05-28 CA CA2689948A patent/CA2689948A1/en not_active Abandoned
- 2008-05-28 US US12/601,322 patent/US8426403B2/en active Active
- 2008-05-28 KR KR1020097027345A patent/KR20100037053A/ko not_active Withdrawn
- 2008-05-28 AU AU2008263207A patent/AU2008263207B2/en not_active Ceased
- 2008-05-28 WO PCT/US2008/006734 patent/WO2008153793A2/en not_active Ceased
- 2008-05-29 CL CL2008001560A patent/CL2008001560A1/es unknown
- 2008-05-29 PE PE2008000920A patent/PE20090363A1/es not_active Application Discontinuation
- 2008-05-29 AR ARP080102261A patent/AR066152A1/es not_active Application Discontinuation
- 2008-05-29 TW TW097119930A patent/TW200914459A/zh unknown
2009
- 2009-11-24 IL IL202315A patent/IL202315A0/en unknown
- 2009-12-01 CO CO09137086A patent/CO6241123A2/es not_active Application Discontinuation
- 2009-12-01 EC EC2009009776A patent/ECSP099776A/es unknown

Also Published As

Publication number	Publication date
BRPI0812170A8 (pt)	2016-02-10
CL2008001560A1 (es)	2009-05-22
CA2689948A1 (en)	2008-12-18
PE20090363A1 (es)	2009-04-01
CO6241123A2 (es)	2011-01-20
ECSP099776A (es)	2010-01-29
US8426403B2 (en)	2013-04-23
AU2008263207B2 (en)	2013-10-03
TW200914459A (en)	2009-04-01
AU2008263207A2 (en)	2010-01-28
KR20100037053A (ko)	2010-04-08
EP2152695A2 (en)	2010-02-17
CN101809016A (zh)	2010-08-18
AU2008263207A1 (en)	2008-12-18
WO2008153793A2 (en)	2008-12-18
MX2009013131A (es)	2010-01-15
US20100256128A1 (en)	2010-10-07
JP5495331B2 (ja)	2014-05-21
WO2008153793A3 (en)	2009-03-19
JP2010529015A (ja)	2010-08-26
AR066152A1 (es)	2009-07-29
RU2009148866A (ru)	2011-07-20
IL202315A0 (en)	2010-06-30

Publication	Publication Date	Title
BRPI0812170A2 (pt)	2014-12-02	Moduladores de gama secretase
BRPI0814256A2 (pt)	2015-02-03	Inibidores de tetrahidropiranocromeno gama secretase
BRPI0813653A2 (pt)	2014-12-30	Compostos de imidazotiazol moduladores de sirtuína
BRPI0813651A2 (pt)	2014-12-30	Compostos de tiazolopiridina moduladores de sirtuína
BRPI0921348A2 (pt)	2019-09-24	moduladores heterocíclicos da gama secretase
BRPI0917394A2 (pt)	2019-09-24	moduladores de mif
BRPI0815135A2 (pt)	2015-02-03	Derivados de azepina como inibidores de gama secretase.
BRPI0818380A2 (pt)	2014-10-07	Combinação de herbicida-protetor
BRPI0921327A2 (pt)	2015-08-25	Combinação de herbicida-protetor
IL201960A0 (en)	2010-06-16	Gamma secretase modulators
IL206172A0 (en)	2010-12-30	Gamma secretase modulators
BRPI0813707A2 (pt)	2014-12-30	Derivados de pirimidinil-piridazinona
BRPI0820112A2 (pt)	2015-05-05	Derivados de isoxazol-piridina
EP2115519A4 (en)	2012-12-05	DYNAMIC OPHTHALMIC OPENING
BRPI0809992A2 (pt)	2014-10-14	Derivados de pirrolopirimidina
BRPI0820113A2 (pt)	2015-05-05	Derivados de isoxazolo-piridazina
BRPI0812155A2 (pt)	2019-09-24	derivados de espiroindolinona
BRPI0817935A2 (pt)	2015-04-07	Derivados de biarila
BRPI0814236A2 (pt)	2015-01-06	Derivados de quinazolinamida
BRPI0813230A2 (pt)	2014-12-23	Moduladores de calicreína 7
BRPI0812518A2 (pt)	2015-03-31	Derivados de indazolamida
BRPI0915991A2 (pt)	2019-09-24	derivados de sulfamida substituída
BRPI0820649A2 (pt)	2015-06-16	Derivados de isoxazalo-pirazina
BRPI0822919A2 (pt)	2015-06-23	Dispositivo de travamento de diferencial
CU23870B1 (es)	2013-03-27	Derivados de ciclopropilamida como moduladores h3

Legal Events

Date	Code	Title	Description
2015-08-25	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 7A ANUIDADE.
2016-02-10	B25D	Requested change of name of applicant approved	Owner name: MERCK SHARP AND DOHME CORP. (US)
2016-02-23	B25G	Requested change of headquarter approved	Owner name: MERCK SHARP AND DOHME CORP. (US)
2016-05-10	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2329 DE 25-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.